All
OTC Treatment Options for Pesky Summer Rashes
The American Skin Association estimated that 50 million Americans are exposed to urushiol yearly, the most common contact allergen in the US.
Influencing and Improving Photoprotection Behaviors in Patients With Xeroderma Pigmentosum
Patients with the rare autosomal recessive genodermatosis are prone to extreme photosensitivity and changes in skin pigmentation.
Soligenix Expands Synthetic Hypericin Psoriasis Study
Additional patients will be enrolled in the phase 2a study after a clear biological signal was demonstrated in initial participants.
New Positive Topline Results From Ruxolitinib Phase 3 Trial for Pediatric AD
The TRuE-AD3 study met its primary endpoint of IGA-TS improvement from baseline at week 8.
DFD-29 Achieves Phase 3 Co-Primary and All Secondary Endpoints for Papulopustular Rosacea Treatment
Based on the positive topline phase 3 results, Journey Medical plans to submit a New Drug Application to the FDA in the second half of 2023.
AAD and VStrong Vitiligo Support Community Receive Inaugural Incyte Ingenuity Awards in Vitiligo
Incyte representative Todd Edwards discusses how the awards help address challenges faced by patients with vitiligo.
Topical Therapeutic Shows Significant Improvement in Mild-to-Moderate Atopic Dermatitis
Alphyn Biologics announced positive results from their Phase 2a trial of AB-101a will lead to a multinational Phase 2b trial soon.
Microneedling Produces Beneficial Acne Vulgaris Outcomes Without Disrupting Skin Structure or Microbiome
Researchers sought to challenge the perception of microneedling as disruptive to the skin and disease states.
Pediatric Necrobiosis Lipoidica Yields Treatment Failure Rate of 40%
Researchers conducted a review of treatments for the rare disease in the pediatric population.
POLL: What is the Average Diagnosis Delay for Patients With HS?
Click here to answer this week's HS poll.
POLL: Are You Attending the 2023 Society for Pediatric Dermatology Meeting?
The 2023 Society for Pediatric Dermatology Meeting kicks off in Asheville, North Carolina, on July 13.
Spesolimab Effective in Treating Generalized Pustular Psoriasis Flares
Boehringer Ingelheim announced that novel antibody treatment can interfere in the IL-36 signaling pathway, reducing flares.
Laura Bush, DMSc, PA-C, DFAAPA, Appointed Next President of SDPA
Bush revealed what she is looking forward to in the coming year and the goals she wants to accomplish.
AD Patient Self-Confidence and Satisfaction Improved With Dupilumab Self-Injection
Dupilumab self-injection has been available to patients in Japan since May 2019.
Blue Light Irradiation Induces Minimal Pigmentation Change in Patients With Melasma
Compared to patients without melasma, blue light irradiation caused minimal changes in patients with melasma.
POLL: Do You Treat More Male or Female Patients With Melanoma?
Click here to answer this week's poll.
Researchers Study Possible Link Between Atopic Dermatitis and Tooth Agenesis
Examining the genes and signaling pathways of development of atopic dermatitis and tooth agenesis reveals possible link between the two diseases.
Hidradenitis Suppurativa Treated with Sonelokimab Shows Significant Improvement
In a clinical trial, patients reported improved quality of life after 12 weeks on sonelokimab.
Dupilumab Effective in Reducing New Allergies and Slowing Atopic March
Findings indicate no rebound effect when participants discontinue dupilumab.
Intelligent Scalpel Uses Artificial Intelligence to Increase Safety of Surgery
Steven Hacker, MD, explains how the electromagnetic resonant scalpel provides a digitized record of the in vivo scalpel path.
The Weekly Roundup: July 2-8
ICYMI, this week we had stories about burn management and treatment in light of the July 4 holiday, pearls from the 2023 World Congress of Dermatology meeting in Singapore, acral lentiginous melanoma in AAPI patients, and more.
Molecular Differentiation of Dermatologic Therapeutics With Christopher Bunick, MD, PhD
Bunick presented 3 sessions at the 2023 World Congress of Dermatology meeting in Singapore.
Tildrakizumab Data Reveals Significant Wellbeing Improvement in Patients With Plaque Psoriasis
Data presented in a poster presentation at the 2023 World Congress of Dermatology meeting in Singapore showed significant improvements to patient quality of life.
PMC48 Probiotic Strain Demonstrates Promise in Hyperpigmentation
Pediococcus acidilactici demonstrated significant clinical efficacy and potential in treating hyperpigmentation.
Partner with Hair Stylists and Give Them the Knowledge to Spot Scalp Concerns
The HEROES program wants to make it easier for stylists to recognize scalp conditions and advise their clients to seek medical help.
Multi-Peptide Eye Serum Reduces Number of Lines and Wrinkles
The study found that using the multi-peptide eye serum twice a day resulted in improved elasticity and firmness.
Kidney Disease-Associated Pruritus and Managing Prurigo Nodularis: Treatment Pearls From Raj Chovatiya, MD, PhD
As the 25th World Congress of Dermatology winds down this week, Chovatiya shares highlights from his sessions in Singapore.
Acral Lentiginous Melanoma More Common in Southeast Asian Patients Than Other Asian American & Pacific Islander Groups
A poster presentation from the 19th Annual Skin of Color Society Scientific Symposium analyzed the differences in presentation of cutaneous melanoma among Asian American and Pacific Islander patients.
Facial Squamous Cell Carcinomas Successfully Treated with Topical Solution and Laser Therapy
Aminolevulinic acid 20% topical solution activated by pulsed dye laser and blue light achieves positive results in treating squamous cell carcinoma.
Oral Treatment of Plaque Psoriasis Achieves Primary and Secondary Endpoints in Trial
Janssen Pharmaceutical Companies announced its oral treatment for moderate to severe plaque psoriasis will be taken to Phase 3 clinical trials.
